Literature DB >> 10867116

The primary care evaluation of mental disorders (PRIME-MD), German version: a comparison with the CIDI.

B Loerch1, A Szegedi, R Kohnen, O Benkert.   

Abstract

There is a need for the development and evaluation of diagnostic instruments suitable for daily use in primary care offices that can improve recognition rates of psychopathology. The objective of this study is the comparison of the German version of the Primary Care Evaluation of Mental Disorders (PRIME-MD), a short structured diagnostic instrument, with the Composite International Diagnostic Interview (CIDI) and to gather some information on the usefulness of the PRIME-MD. Seven hundred and four patients were assessed three times, once using the physician's clinical judgement, subsequently, administering the PRIME-MD, DSM-IV version and finally, with the CIDI. The CIDI was administered on a different occasion within 1 week after the PRIME-MD evaluation by independent interviewers over the telephone. At the end of the study, the participating physicians answered a few feedback questions on the usefulness of PRIME-MD. Sensitivity (0.73), specificity (0.67), overall accuracy (0.70) were good for any psychiatric disorder. According to the diagnostic categories of mood disorders, anxiety disorders, eating disorders, and alcohol-related disorders, the sensitivity of PRIME-MD was good (0.67-0.80). For somatoform disorders, sensitivity was poor. Specificity, accuracy, and negative predictive values were good-to-excellent for all diagnostic categories. Kappas range from poor (0.12 somatoform disorders) to satisfactory (0.62 alcohol related disorders). Average time for administering PRIME-MD was 11 min. The results demonstrated that the German version of the PRIME-MD may be useful in primary care settings to enhance recognition of mental disorders by primary care physicians, even without being formally trained in diagnosing mental disorders.

Entities:  

Mesh:

Year:  2000        PMID: 10867116     DOI: 10.1016/s0022-3956(00)00005-4

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  7 in total

1.  Human and economic burden of GAD, subthreshold GAD, and worry in a primary care sample.

Authors:  Sarah J Kertz; Janet Woodruff-Borden
Journal:  J Clin Psychol Med Settings       Date:  2011-09

2.  The outcomes among patients presenting in primary care with a physical symptom at 5 years.

Authors:  Jeffrey L Jackson; Mark Passamonti
Journal:  J Gen Intern Med       Date:  2005-11       Impact factor: 5.128

3.  Abuse and mental disorders among women at walk-in clinics in Trinidad: a cross-sectional study.

Authors:  Rohan G Maharaj; Colanne Alexander; Candace H Bridglal; Aysha Edwards; Hassina Mohammed; Teri-Ann Rampaul; Sharlene Sanchez; Gina P Tanwing; Kristy Thomas
Journal:  BMC Fam Pract       Date:  2010-03-30       Impact factor: 2.497

4.  Meta-analyses of agreement between diagnoses made from clinical evaluations and standardized diagnostic interviews.

Authors:  David C Rettew; Alicia Doyle Lynch; Thomas M Achenbach; Levent Dumenci; Masha Y Ivanova
Journal:  Int J Methods Psychiatr Res       Date:  2009-09       Impact factor: 4.035

5.  Co-morbid psychological dysfunction is associated with a higher risk of asthma exacerbations: a systematic review and meta-analysis.

Authors:  Li Zhang; Xin Zhang; Jing Zheng; Lan Wang; Hong-Ping Zhang; Lei Wang; Gang Wang
Journal:  J Thorac Dis       Date:  2016-06       Impact factor: 2.895

6.  The relations between symptoms, somatic and psychiatric conditions, life satisfaction and perceived health. A primary care based study.

Authors:  Ahmad Al-Windi
Journal:  Health Qual Life Outcomes       Date:  2005-04-27       Impact factor: 3.186

7.  Depression in working adults: comparing the costs and health outcomes of working when ill.

Authors:  Fiona Cocker; Jan M Nicholson; Nicholas Graves; Brian Oldenburg; Andrew J Palmer; Angela Martin; Jenn Scott; Alison Venn; Kristy Sanderson
Journal:  PLoS One       Date:  2014-09-02       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.